Purchases and Sales Made in Q3 2024 in Arcutis Biotherapeutics, Inc. (ARQT)
This table provides information about the institutional ownership of Arcutis Biotherapeutics, Inc. (ARQT) during Q3 2024. The information is specifically focused on institutions that hold shares of Arcutis Biotherapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2024
Q3 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-577K- 86.48% |
$4.8M - $6.35M
|
90.2K
$1.27M
|
|
Nov 12, 2024
Q3 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-790K- 70.93% |
$6.57M - $8.69M
|
324K
$4.57M
|
|
Nov 13, 2024
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-1.08M- 57.49% |
$9M - $11.9M
|
800K
$11.3M
|